Applied DNA Sciences Inc (APDN)

[mcsharkey]

Yeah Park, my glow from recent funding from our own Board members fading a bit. STILL, provides some glimmer of hope.

LinearRX MAY take off BUT, poor track record hard to dismiss.

Extension of unexercised options out to 2022 kind of diminished any luster.

Lack of progress by Theracann also cause for concern here.

What we do have here. I believe in the premises of our arrays of technologies and shelf lifes. Marketability needs a new hand on the rudder.

Nuff said. My opinion.

GLTUA
VR
Mike Sharkey